Biotest GmbH KGaA (LTS:0N6Z) FCF Margin %: 0.00% (As of . 20)


What is Biotest GmbH KGaA FCF Margin %?

Biotest GmbH KGaA LTS:0N6Z FCF Margin % is 0.00% as of . 20.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Biotest GmbH KGaA's Free Cash Flow for the six months ended in . 20 was £0.00 Mil. Biotest GmbH KGaA's Revenue for the six months ended in . 20 was £0.00 Mil. Therefore, Biotest GmbH KGaA's FCF Margin % for the quarter that ended in . 20 was 0.00%.

As of today, Biotest GmbH KGaA's current FCF Yield % is 0.00%.

The historical rank and industry rank for Biotest GmbH KGaA's FCF Margin % or its related term are showing as below:


LTS:0N6Z's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -82.65
* Ranked among companies with meaningful FCF Margin % only.

Biotest GmbH KGaA FCF Margin % Related Terms

Biotest GmbH KGaA FCF Margin % Historical Data

* Premium members only.

The historical data trend for Biotest GmbH KGaA's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotest GmbH KGaA FCF Margin % Chart

Biotest GmbH KGaA Annual Data
Trend
FCF Margin %

Biotest GmbH KGaA Semi-Annual Data
FCF Margin %

LTS:0N6Z vs : FCF Margin % Comparison

For the Biotechnology subindustry, Biotest GmbH KGaA's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotest GmbH KGaA FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biotest GmbH KGaA's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Biotest GmbH KGaA's FCF Margin % falls into.


Biotest GmbH KGaA FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Biotest GmbH KGaA's FCF Margin for the fiscal year that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (A: . 20 )/Revenue (A: . 20 )
=/
= %

Biotest GmbH KGaA's FCF Margin for the quarter that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Biotest GmbH KGaA (LTS:0N6Z) has a FCF Margin % of 0.00% as of . 20. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Biotest GmbH KGaA and its competitors.
Is Biotest GmbH KGaA's FCF Margin % too high?
Biotest GmbH KGaA's current FCF Margin % is 0.00%.
How does Biotest GmbH KGaA's FCF Margin % compare to ?
Biotest GmbH KGaA's FCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Biotest GmbH KGaA and its competitors. Biotest GmbH KGaA's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotest GmbH KGaA stock overvalued right now?
Biotest GmbH KGaA (LTS:0N6Z) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Biotest GmbH KGaA (LTS:0N6Z), the current FCF Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biotest GmbH KGaA Business Description

Comparable Companies
Biotest GmbH & Co KGaA is a specialist in haematology, clinical immunology, and intensive care medicine. The group develops, manufactures, and markets plasma proteins and biotherapeutic drugs. The group's value chain extends from pre-clinical and clinical development to world-wide marketing and distribution. It manufactures immunoglobulins, clotting factors, and albumins, which are derived from human blood plasma. The group markets its products in Europe, the Middle East, China, Australia, Africa, and the USA.